Raymond M. Wolfe [1]

Businesses spent $400 billion on research and development performance in the United States in 2017, a 6.8% increase from 2016 (table 1). Funding from the companies' own sources was $339 billion in 2017, a 6.7% increase from 2016. Funding from other sources was $61 billion in 2017 and $57 billion in 2016. Data for this InfoBrief are from the 2016 Business R&D and Innovation Survey (BRDIS) and the 2017 Business Research and Development Survey (BRDS), both developed and cosponsored by the National Center for Science and Engineering Statistics (NCSES) within the National Science Foundation and by the U.S. Census Bureau.[2]

TABLE 1. Funds spent for business R&D performed in the United States, by type of R&D, source of funds, and size of company: 2016–17
(Millions of U.S. dollars)
Selected characteristic and company size 2016 2017

i = more than 50% of the estimate is a combination of imputation and reweighting to account for nonresponse.

NA = not available.

a Domestic R&D performance is the cost of R&D paid for by the respondent company and others outside of the company and performed by the company.
b R&D is planned, creative work aimed at discovering new knowledge or devising new applications of available knowledge. This includes (1) activities aimed at acquiring new knowledge or understanding without specific immediate commercial applications or uses (basic research), (2) activities aimed at solving a specific problem or meeting a specific commercial objective (applied research), and (3) systematic use of research and practical experience and resulting in additional knowledge, which is directed to producing new or improved goods, services, or processes (development).
c Includes foreign subsidiaries of U.S. companies.
d Includes companies located inside and outside the United States; U.S. state government agencies and laboratories; U.S. universities, colleges, and academic researchers; and all other organizations located inside and outside the United States.
e The Business R&D and Innovation Survey did not include companies with fewer than five domestic employees.
f The Business Research and Development Survey does not include companies with fewer than ten domestic employees.

NOTES: Detail may not add to total because of rounding. Statistics are representative of companies located in the United States that performed or funded R&D. Excludes data for federally funded research and development centers.

SOURCE: National Center for Science and Engineering Statistics, National Science Foundation, and U.S. Census Bureau, Business R&D and Innovation Survey and Business Research and Development Survey.

Table 1 Source Data: Excel file

Domestic R&D performancea 374,685 400,100
Type of R&Db
Basic research 24,644 24,829
Applied research 61,020 62,132
Development 289,021 313,139
Paid for by the companyc 317,731 339,036
Basic research 19,143 18,732
Applied research 48,806 49,149
Development 249,782 271,155
Paid for by others 56,954 61,065
Basic research 5,501 6,097
Applied research 12,213 12,984
Development 39,239 41,984
Source of funds
Federal 23,772 24,277 i
Otherd 33,182 36,788
Size of company (number of domestic employees)
Micro companiese
5–9 1,581 i NA
Small companiesf
10–19 4,958 i 3,311
20–49 9,662 i 9,435
Medium companies
50–99 9,298 10,141
100–249 14,875 17,216
Large companies
250–499 13,092 14,103
500–999 14,450 17,871
1,000–4,999 63,971 65,112
5,000–9,999 40,633 40,198
10,000–24,999 65,594 73,485
25,000 or more 136,571 149,227

R&D Performance, by Type of R&D, Industrial Sector, and Source of Funding

In 2017, of the $400 billion companies spent on R&D, $25 billion (6%) was spent on basic research, $62 billion (16%) on applied research, and $313 billion (78%) on development. The distribution was similar to the 2016 distribution (7%, 16%, and 77%, respectively) (table 1). In 2017, companies in manufacturing industries performed $257 billion (64%) of domestic R&D, defined as R&D performed in the 50 states and Washington, DC (table 2).

TABLE 2. Funds spent for business R&D performed in the United States, by source of funds, selected industry, and company size: 2017
(Millions of U.S. dollars)
Industry, NAICS code, and company size All R&Da Paid for by the
companyb
Paid for by others
Total Federal Companies All other
organizationsd
Domestic Foreignc

* = amount is less than $500,000; D = suppressed to avoid disclosure of confidential information; i = more than 50% of the estimate is a combination of imputation and reweighting to account for nonresponse.

NAICS = North American Industry Classification System; nec = not elsewhere classified.

a All R&D is the cost of domestic R&D paid for by the respondent company and others outside of the company and performed by the company.
b Includes foreign subsidiaries of U.S. companies ($19.2 billion).
c Includes foreign parent companies of U.S. subsidiaries ($15.4 billion) and unaffiliated companies ($3.0 billion). Excludes funds from foreign subsidiaries to U.S. companies paid for through inter-company transactions ($19.2 billion).
d Includes U.S. state government agencies and laboratories ($0.1 billion); U.S. universities, colleges, and academic researchers ($0.1 billion); and all other organizations located inside ($0.5 billion) and outside the United States ($0.2 billion).
e The Business Research and Development Survey does not include companies with fewer than 10 employees.

NOTES: Detail may not add to total because of rounding. Statistics are representative of companies located in the United States that performed or funded R&D. Industry classification was based on dominant business code for domestic R&D performance, where available. For companies that did not report business codes, the classification used for sampling was assigned. Excludes data for federally funded research and development centers.

SOURCE: National Center for Science and Engineering Statistics, National Science Foundation, and U.S. Census Bureau, Business Research and Development Survey, 2017.

Table 2 Source Data: Excel file

All industries, 21–33, 42–81 400,100 339,036 61,065 24,277 i 17,494 18,404 890 i
Manufacturing industries, 31–33 257,227 216,155 41,072 18,889 i 6,229 15,434 520 i
Chemicals, 325 74,977 63,285 11,692 205 2,696 8,707 84
Pharmaceuticals and medicines, 3254 66,202 55,229 10,973 186 2,685 8,019 83
Other 325 8,775 8,056 719 19 11 688 1
Machinery, 333 13,197 12,257 940 170 130 i 640 0
Computer and electronic products, 334 78,575 69,942 8,633 3,937 D D D
Electrical equipment, appliance, and components, 335 4,291 4,110 181 38 65 77 i 1 i
Transportation equipment, 336 53,292 34,629 18,663 i 14,433 i D 2,219 D
Automobiles, bodies, trailers, and parts, 3361–63 23,881 21,137 2,745 D D D D
Aerospace products and parts, 3364 26,383 11,903 14,480 i D 1,209 i D D
Other 336 3,028 1,589 1,438 D D D D
Manufacturing nec, other 31–33 32,895 31,932 963 i 106 i D D D
Nonmanufacturing industries, 21–23, 42–81 142,874 122,881 19,993 5,388 11,265 i 2,970 370 i
Information, 51 80,252 78,898 1,354 98 117 1,138 1
Software publishers, 5112 34,264 33,201 1,062 62 66 933 1
Other 51 45,988 45,697 292 36 51 205 0
Finance and insurance, 52 7,616 7,565 51 0 * i 0 51
Professional, scientific, and technical services, 54 36,922 18,972 17,951 5,256 10,874 i 1,530 291 i
Computer systems design and related services, 5415 13,327 11,669 1,658 995 339 201 123
Scientific R&D services, 5417 17,321 2,817 14,504 3,200 10,024 i 1,160 120 i
Other 54 6,274 4,486 1,789 1,061 511 i 169 48 i
Nonmanufacturing nec, other 21–23, 42–81 18,084 17,446 637 34 274 302 27
Size of company (number of domestic employees)
Small companies
10–19e 3,311 2,402 909 485 D D D
20–49 9,435 7,593 1,842 605 632 531 74 i
Medium companies
50–99 10,141 8,070 2,071 659 668 599 145
100–249 17,216 13,514 3,703 1,241 866 1,524 72
Large companies
250–499 14,103 11,773 2,331 592 834 863 42
500–999 17,871 16,295 1,576 221 311 1,038 6
1,000–4,999 65,112 52,341 12,771 1,461 2,724 8,531 55
5,000–9,999 40,198 32,701 7,497 1,525 4,938 i 1,011 23
10,000–24,999 73,485 63,415 10,070 3,514 2,627 i 3,917 12 i
25,000 or more 149,227 130,931 18,295 i 13,976 i D D D

Most of the funding was from these companies' own funds (84%). Companies in nonmanufacturing industries performed $143 billion of domestic R&D (36% of total domestic R&D performance), 86% of which was paid for from companies' own funds.

The U.S. federal government was the chief source of external funding for R&D (also referred to as R&D paid for by others) across all industries. Of the $61 billion paid for by others, the federal government accounted for $24 billion, most of which came from the Department of Defense ($17 billion) (data available in the full set of data tables). Ninety-seven percent of federal government funding went toward transportation equipment (North American Industry Classification System [NAICS] code 336) ($14 billion), professional, scientific, and technical services (NAICS 54) ($5 billion), and computer and electronic products (NAICS 334) ($4 billion). Next among external funders were foreign companies ($18 billion)—including foreign parent companies of U.S. subsidiaries—and other U.S. companies ($17 billion) (table 2). (See "Survey Information and Data Availability" for information on the availability of data tables with full industry detail.)

R&D Performance, by Company Size

Small- and medium-sized companies (10 to 249 domestic employees) performed 10% of the nation's total business R&D in 2017 (table 1).[3] In these companies, the R&D-to-sales ratio (or R&D intensity) was 8.3% (table 1 and table 3). These companies accounted for 5% of sales and employed 7% of the 19.9 million employees who worked for R&D-performing or R&D-funding companies. They employed 18% of the 1.6 million employees engaged in business R&D in the United States.

TABLE 3. Sales, R&D intensity, and employment for companies that performed or funded business R&D, by selected industry and company size: 2017
Industry, NAICS code, and company size Domestic net sales
(US$millions)a
R&D intensity
(%)b
Domestic employment
(thousands)c
Total R&Dd

NAICS = North American Industry Classification System; nec = not elsewhere classified.

a Dollar values for goods sold or services rendered by R&D-performing or R&D-funding companies located in the United States to customers outside of the company, including the U.S. federal government, foreign customers, and the company's foreign subsidiaries. Included are revenues from a company's foreign operations and subsidiaries and from discontinued operations. If a respondent company is owned by a foreign parent company, sales to the parent company and to affiliates not owned by the respondent company are included. Excluded are intracompany transfers, returns, allowances, freight charges, and excise, sales, and other revenue-based taxes.
b R&D intensity is the cost of domestic R&D paid for by the respondent company and others outside of the company and performed by the company divided by domestic net sales of companies that performed or funded R&D.
c Data recorded on 12 March represent employment figures for the year.
d Includes researchers, R&D managers, technicians, clerical staff, and others assigned to R&D groups.
e The Business Research and Development Survey does not include companies with fewer than 10 employees.

NOTES: Detail may not add to total because of rounding. Sales, R&D intensity, and total domestic employment statistics are representative of companies located in the United States that performed or funded R&D; R&D employment statistics are representative of companies located in the United States that performed R&D. Industry classification was based on dominant business code for domestic R&D performance, where available. For companies that did not report business codes, the classification used for sampling was assigned. Excludes data for federally funded research and development centers.

SOURCE: National Center for Science and Engineering Statistics, National Science Foundation, and U.S. Census Bureau, Business Research and Development Survey, 2017.

Table 3 Source Data: Excel file

All industries, 21–33, 42–81 9,682,692 4.1 19,893 1,609
Manufacturing industries, 31–33 5,423,997 4.7 9,919 916
Chemicals, 325 901,859 8.3 1,234 174
Pharmaceuticals and medicines, 3254 466,391 14.2 518 127
Other 325 435,468 2.0 716 47
Machinery, 333 323,082 4.1 839 85
Computer and electronic products, 334 697,118 11.3 1,200 258
Electrical equipment, appliance, and components, 335 113,434 3.8 291 29
Transportation equipment, 336 1,173,095 4.5 1,771 172
Automobiles, bodies, trailers, and parts, 3361–63 756,472 3.2 852 92
Aerospace products and parts, 3364 350,201 7.5 710 67
Other 336 66,422 4.6 209 13
Manufacturing nec, other 31–33 2,215,409 1.5 4,584 198
Nonmanufacturing industries, 21–23, 42–81 4,258,695 3.4 9,974 693
Information, 51 1,192,143 6.7 1,945 305
Software publishers, 5112 230,197 14.9 572 134
Other 51 961,946 4.8 1,373 171
Finance and insurance, 52 736,468 1.0 1,211 36
Professional, scientific, and technical services, 54 400,375 9.2 1,330 235
Computer systems design and related services, 5415 152,271 8.8 456 78
Scientific R&D services, 5417 69,134 25.1 283 86
Other 54 178,970 3.5 591 71
Nonmanufacturing nec, other 21–23, 42–81 1,929,709 0.9 5,488 117
Size of company (number of domestic employees)
Small companiese
10–19 24,126 13.7 73 26
20–49 86,131 11.0 285 78
Medium companies
50–99 116,967 8.7 366 74
100–249 258,031 6.7 669 111
Large companies
250–499 280,138 5.0 686 87
500–999 368,694 4.8 849 90
1,000–4,999 1,249,905 5.2 2,668 275
5,000–9,999 939,230 4.3 1,710 185
10,000–24,999 1,851,278 4.0 3,007 248
25,000 or more 4,508,191 3.3 9,581 437

Large companies with 250 to 24,999 domestic employees performed 53% of the nation's total business R&D in 2017, and their R&D intensity was 4.5%. They accounted for 48% of sales, employed 45% of those who worked for R&D-performing or R&D-funding companies, and employed 55% of R&D employees in the United States.

The largest companies (25,000 or more domestic employees) performed 37% of the nation's total business R&D in 2017, and their R&D intensity was 3.3%. They accounted for 47% of sales, employed 48% of those who worked for R&D-performing or R&D-funding companies, and employed 27% of R&D employees in the United States.

R&D Performance, by State

Business R&D is concentrated in a relatively small number of states. In 2017, companies reported $339 billion of domestic R&D paid for by the company. Businesses in California alone accounted for 35% of this amount (table 4). Other states with large amounts of business R&D paid for by companies' own funds in 2017 were Washington (6% of the national total), Massachusetts (6%), Michigan (6%), Texas (5%), New York (4%), New Jersey (4%), Illinois (4%), and Pennsylvania (3%).[4]

TABLE 4. Funds spent for business R&D performed in the United States, by state and source of funds: 2017
(Millions of U.S. dollars)
State All R&Da Paid for by
the company
Paid for by
others

i = more than 50% of the estimate is a combination of imputation and reweighting to account for nonresponse.

a All R&D is the cost of domestic R&D paid for by the respondent company and others outside of the company and performed by the company.
b Includes data reported that were not allocated to a specific state by multi-establishment companies. For single-establishment companies, data reported were allocated to the state in the address used to mail the survey form.

NOTES: Detail may not add to totals because of rounding. Statistics are representative of companies located in the United States that performed or funded R&D. Excludes data for federally funded research and development centers.

SOURCE: National Center for Science and Engineering Statistics, National Science Foundation, and U.S. Census Bureau, Business Research and Development Survey, 2017.

Table 4 Source Data: Excel file

United States 400,100 339,036 61,065
Alabama 1,896 968 928
Alaska 912 905 7
Arizona 6,338 4,476 1,862
Arkansas 466 442 24
California 132,473 120,111 12,362
Colorado 4,703 3,828 875
Connecticut 8,694 6,423 2,272
Delaware 2,048 1,445 i 603
District of Columbia 406 279 127
Florida 6,463 4,496 1,966 i
Georgia 6,450 5,085 1,365 i
Hawaii 169 105 64
Idaho 1,747 1,527 220
Illinois 14,399 12,743 1,655 i
Indiana 6,283 5,394 889
Iowa 2,938 2,195 743
Kansas 2,212 1,486 726 i
Kentucky 983 758 225
Louisiana 297 243 53
Maine 292 257 35
Maryland 5,595 3,106 2,488 i
Massachusetts 23,655 18,912 4,743
Michigan 21,042 19,101 1,941
Minnesota 7,146 6,633 513
Mississippi 266 221 45
Missouri 5,299 i 3,433 1,866 i
Montana 133 114 18
Nebraska 592 470 122 i
Nevada 624 439 186
New Hampshire 1,361 754 607 i
New Jersey 16,405 13,228 3,177
New Mexico 802 298 503 i
New York 15,671 13,430 2,241
North Carolina 10,246 7,502 2,744 i
North Dakota 304 276 28
Ohio 9,769 6,697 3,071
Oklahoma 833 775 58
Oregon 7,691 7,426 265
Pennsylvania 10,986 9,576 1,410
Rhode Island 730 657 73
South Carolina 1,370 1,212 158
South Dakota 199 189 10
Tennessee 1,407 1,172 235
Texas 21,002 17,752 3,250
Utah 2,846 2,171 675
Vermont 253 241 11
Virginia 4,332 2,659 1,674 i
Washington 21,462 20,820 642
West Virginia 212 182 30
Wisconsin 5,436 4,777 659
Wyoming 87 i 82 i 5
Undistributed fundsb 2,181 1,561 620

Sales, R&D Intensity, and Employment of Companies that Performed or Funded R&D

U.S. companies that performed or funded R&D reported domestic net sales of $10 trillion in 2017 (table 3).[5] For all industries, the R&D intensity was 4.1%; for manufacturers, 4.7%; and for nonmanufacturers, 3.4%. Manufacturing industries with high levels of R&D intensity in 2017 were pharmaceuticals and medicines (NAICS 3254) (14.2%), computer and electronic products (NAICS 334) (11.3%), and aerospace products and parts (NAICS 3364) (7.5%). Among the nonmanufacturing industries, industries with high levels of R&D intensity were scientific R&D services (NAICS 5417) (25.1%), software publishers (NAICS 5112) (14.9%), and computer systems design and related services (NAICS 5415) (8.8%).

Businesses that performed or funded R&D employed 19.9 million people in the United States in 2017. Approximately 1.6 million (8%) were R&D employees.[6] Not surprisingly, industries with high levels of R&D intensity also had high numbers of R&D employees: computer and electronic products (NAICS 334) (258,000 R&D employees), pharmaceuticals and medicines (NAICS 3254) (127,000), and aerospace products and parts (NAICS 3364) (67,000). Nonmanufacturing industry groups with high numbers of R&D employees were software publishers (NAICS 5112) (134,000 R&D employees), scientific R&D services (NAICS 5417) (86,000), and computer systems design and related services (NAICS 5415) (78,000) (table 3).

Capital Expenditures

Companies that performed or funded R&D in the United States in 2017 spent $587 billion on assets with expected useful lives of more than 1 year (table 5). Of this amount, $32 billion (5%) was spent on structures, equipment, software, and other assets used for R&D: $16 billion by manufacturing industries and $16 billion by nonmanufacturing industries. Manufacturing industries with high levels of capital expenditures on assets used for R&D in 2017 were pharmaceuticals and medicines (NAICS 3254) ($4.4 billion, 14% of capital expenditures on assets used for R&D), semiconductor and other electronic products (NAICS 3344) ($2.2 billion, 7%), and automobiles, bodies, trailers, and parts (NAICS 3361–63) ($1.2 billion, 4%). Among the nonmanufacturing industries with high levels of capital assets used for R&D were telecommunications services (NAICS 517) ($3.2 billion, 10%), computer systems design and related services (NAICS 5415) ($2.0 billion, 6%), and software publishers (NAICS 5112) ($1.1 billion, 4%).

TABLE 5. Capital expenditures in the United States and for domestic R&D paid for and performed by the company, by type of expenditure, industry, and company size: 2017
(Millions of U.S. dollars)
Selected industry, NAICS code, and company size Totalb Used for domestic R&Da
Totalb,c Structuresd Equipment Capitalized
software
All other and
undistributede

D = data withheld to avoid disclosing operations of individual companies; i = more than 50% of the estimate is a combination of imputation and reweighting to account for nonresponse.

NAICS = North American Industry Classification System; nec = not elsewhere classified.

a Domestic R&D is the R&D paid for by the respondent company and others outside of the company and performed by the company.
b Capital expenditures are payments by a business for assets that usually have a useful life of more than 1 year. The value of assets acquired or improved through capital expenditures is recorded on a company's balance sheet. BRDIS statistics exclude the cost of assets acquired through mergers and acquisitions and purchased land.
c Capital expenditures for long-lived assets used in a company's R&D operations are not included in its R&D expense, but any depreciation recorded for those assets is included in its R&D expense. For 2017, depreciation associated with domestic R&D paid for and performed by the company was $13.5 billion and with domestic R&D performed by the company and paid for by others was $1.6 billion.
d Includes the cost of purchased or improved buildings and other facilities that are fixed to the land.
e Includes the cost of other capital expenditures, including purchased patents and other intangible assets, and expenditures not distributed among the categories shown.
f The Business Research and Development Survey does not include companies with fewer than 10 employees.

NOTES: Detail may not add to total because of rounding. Statistics are representative of companies located in the United States that performed or funded R&D. Industry classification was based on dominant business code for domestic R&D performance, where available. For companies that did not report business codes, the classification used for sampling was assigned. Excludes data for federally funded research and development centers.

SOURCE: National Center for Science and Engineering Statistics, National Science Foundation, and U.S. Census Bureau, Business Research and Development Survey, 2017.

Table 5 Source Data: Excel file

All industries, 21–33, 42–81 587,332 31,885 3,541 14,898 8,539 4,907
Manufacturing industries, 31–33 237,691 15,659 2,662 9,265 1,611 2,122
Chemicals, 325 41,932 5,394 1,788 2,250 469 887
Pharmaceuticals and medicines, 3254 16,211 4,394 1,565 1,641 399 789
Other 325 25,721 1,000 223 609 70 98
Machinery, 333 11,707 866 90 548 101 127
Computer and electronic products, 334 30,411 4,590 224 3,529 527 310
Communication equipment, 3342 2,920 843 32 653 59 99
Semiconductor and other electronic products, 3344 13,312 i 2,173 i 126 i 1,763 i 212 i 73 i
Other 334 14,179 1,574 66 1,113 256 138
Electrical equipment, appliance, and components, 335 3,067 i 227 7 i 130 i 15 i 76 i
Transportation equipment, 336 60,636 1,791 158 1,141 222 271
Automobiles, bodies, trailers, and parts, 3361–63 46,164 1,177 103 759 143 173
Aerospace products and parts, 3364 11,396 522 39 340 77 67
Other 336 3,076 92 16 42 2 31
Manufacturing nec, other 31–33 89,938 2,791 395 1,667 277 451
Nonmanufacturing industries, 21–23, 42–81 349,640 16,226 879 5,633 6,928 2,785
Information, 51 117,469 7,730 555 3,637 2,739 800
Software publishers, 5112 18,215 1,128 113 714 209 92
Telecommunications services, 517 71,766 3,189 D 850 1,443 D
Other 51 27,488 3,413 D 2,073 1,087 D
Finance and insurance, 52 20,670 2,753 25 i 426 1,758 544
Professional, scientific, and technical services, 54 13,853 3,072 187 881 1,402 602
Computer systems design and related services, 5415 6,156 2,020 97 552 1,128 243
Scientific R&D services, 5417 2,593 717 79 260 60 318
Other 54 5,104 335 11 69 214 41
Nonmanufacturing nec, other 21–23, 42–81 197,648 2,671 112 689 1,029 839
Size of company (number of domestic employees)
Small companiesf
10–19 1,642 319 13 133 64 109
20–49 6,837 924 43 413 104 364
Medium companies
50–99 7,618 855 200 391 180 84
100–249 12,045 1,989 136 1,265 237 351
Large companies
250–499 10,452 1,109 78 549 252 231
500–999 21,640 1,705 207 572 428 497
1,000–4,999 61,271 4,733 589 2,021 1,376 747
5,000–9,999 68,790 4,019 667 1,371 1,157 823
10,000–24,999 124,057 5,790 688 2,553 1,558 991
25,000 or more 272,980 10,442 919 5,630 3,182 710

Survey Information and Data Availability

The 2016 cycle of BRDIS was the last cycle that collected R&D data for companies with five to nine employees and on business innovation activities. The Annual Business Survey, also co-sponsored by NCSES and the U.S. Census Bureau, will collect R&D data from companies with fewer than 10 employees and more comprehensive data on innovation from all companies for 2017 and beyond. Beginning with the 2017 data collection, BRDIS—the Business R&D and Innovation Survey—became the Business Research and Development Survey (BRDS).

In this InfoBrief, money amounts are expressed in current U.S. dollars and are not adjusted for inflation. A company is defined as a business organization located in the United States, either U.S. owned or a U.S. affiliate of a foreign parent company, of one or more establishments under common ownership or control.

The samples for BRDIS and BRDS were selected to represent all for-profit, nonfarm companies that were publicly or privately held and had five or more employees (BRDIS) or 10 or more employees (BRDS) in the United States. Estimates produced from the surveys and presented in this InfoBrief are restricted to companies that performed or funded R&D, either domestically or abroad. Because the statistics from the surveys are based on samples, they are subject to both sampling and nonsampling errors (see technical notes in the data tables reports at https://www.nsf.gov/statistics/srvyindustry/).

For 2016, a total of 44,861 companies were sampled to represent the population of 1,485,151 companies; for 2017, a total of 45,075 companies were sampled, representing 1,097,607 companies. The representative population decreased primarily because the criteria for inclusion in the sample was changed for 2017. Previously, companies with fewer than 5 employees, or less than 10 employees if classified in other nonmanufacturing (ONM), were deemed out of scope. For 2017, companies with fewer than 10 employees, regardless of industry, were deemed out of scope because these companies are now covered in the Annual Business Survey. This change accounted for a decrease in population of approximately 400,000 companies.

The actual numbers of reporting units in the sample that remained within the scope of the survey between sample selection and tabulation were 42,122 for 2016 and 41,998 for 2017. These lower counts represent the number of reporting units that were determined to be within the scope of the survey after all data collected were processed. Reasons for the reduced counts include mergers, acquisitions, and instances where companies had fewer than five paid employees (BRDIS) or ten employees (BRDS) in the United States or had gone out of business in the interim. Of these in-scope reporting units, 80.2% were considered to have met the criteria for a complete response to the 2016 survey; 74.5% met the 2017 complete response criteria. Coverage of the previous year's known positive R&D stratum for 2016 was 84.0%; the coverage rate for 2017 was 84.9%. Industry classification was based on the dominant business activity for domestic R&D performance where available. For reporting units that did not report business activity codes for R&D, the classification used for sampling was assigned.

The full set of data tables from this survey will be available in the report Business Research and Development: 2017 (https://www.nsf.gov/statistics/srvybrds/). Individual data tables and tables with relative standard errors and imputation rates from the 2017 survey are available in advance of the full report. Statistics for new items added to the survey for 2017 are available in the full set of tables, including for R&D paid for by foreign government agencies and by foreign universities, colleges and academic researchers.

References

Anderson G and Kindlon A. 2019. Indicators of R&D in Small Businesses: Data from the 2009-15 Business R&D and Innovation Survey. InfoBrief NSF 19-316. Alexandria, VA: National Science Foundation, National Center for Science and Engineering Statistics. Available at https://www.nsf.gov/statistics/2019/nsf19316/.

Organization for Economic Cooperation and Development (OECD). 2015. Frascati Manual: Guidelines for Collecting and Reporting Data on Research and Experimental Development, The Measurement of Scientific, Technological, and Innovation Activities. Paris. OECD Publishing. Available at https://www.oecd-ilibrary.org/science-and-technology/frascati-manual-2015_9789264239012-en.

Shackelford B and Wolfe R. 2016. Five States Account for Half of U.S. Business R&D Performance in 2013: New Data for Metropolitan Areas Available. InfoBrief NSF 16-317. Arlington, VA: National Science Foundation, National Center for Science and Engineering Statistics. Available at http://www.nsf.gov/statistics/2016/nsf16317/.

Shackelford B and Wolfe R. 2019. Over Half of U.S. Business R&D Performed in 10 Metropolitan Areas in 2015. InfoBrief NSF 19-322. Alexandra, VA: National Science Foundation, National Center for Science and Engineering Statistics. Available at http://www.nsf.gov/statistics/2019/nsf19322/.

Notes

[1] Raymond M. Wolfe, Research and Development Statistics Program, National Center for Science and Engineering Statistics, National Science Foundation, 2415 Eisenhower Avenue, Suite W14200, Alexandria, VA 22314 (rwolfe@nsf.gov; 703-292-7789).

[2] The National Science Foundation has co-sponsored an annual business R&D survey since 1953. The Survey of Industrial Research and Development (SIRD) collected data for 1953–2007, and its successor, the Business R&D and Innovation Survey, collected data for 2008–16. Beginning with 2017, the collection of innovation data was moved to the Annual Business Survey, another survey co-sponsored with the U.S. Census Bureau, and the business R&D data collection reported here was renamed the Business Research and Development Survey.

[3] Company size classifications changed for 2017 in response to the revised Frascati Manual (OECD 2015). Anderson and Kindlon (2019) provide estimates of R&D performance and employment using these new classifications over the 2008–15 time period. The authors also compare the trends to those observed in SIRD for the time prior to 2008.

[4] In addition to statistics for all states, below-state level statistics are available in the full set of tables and also in other InfoBriefs; see Shackelford and Wolfe (2016) and (2019).

[5] Determining the amount of domestic net sales and operating revenues was left to the reporting company. However, guidance was given to include revenues from foreign operations and subsidiaries and from discontinued operations and to exclude intracompany transfers, returns, allowances, freight charges, and excise, sales, and other revenue-based taxes.

[6] Employment statistics in this InfoBrief are head counts. Full-time equivalent statistics are available in the data tables. R&D employees include researchers (defined as R&D scientists and engineers and their managers) and the technicians, technologists, and support staff members who work on R&D or who provide direct support to R&D activities.